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AD: Atopic dermatitis
OR: Odds ratio
RR: Relative riskBackground: Findings on pet exposure and the risk of atopic
dermatitis (AD) in children are inconsistent.
Objective: With the aim to summarize the results of exposure to
different pets on AD, we undertook a meta-analysis of
epidemiologic studies on this issue.
Methods: In August 2012, we conducted a systematic literature
search in Medline and Embase. We included analytic studies
considering exposure to dogs, cats, other pets, or pets overall
during pregnancy, infancy, and/or childhood, with AD
assessment performed during infancy or childhood. We
calculated summary relative risks and 95% CIs using both
fixed- and random-effects models. We computed summary
estimates across selected subgroups.
Results: Twenty-six publications from 21 birth cohort studies
were used in the meta-analyses. The pooled relative risks of AD
for exposure versus no exposure were 0.72 (95% CI, 0.61-0.85;
I2 5 46%; results based on 15 studies) for exposure to dogs, 0.94
(95% CI, 0.76-1.16; I2 5 54%; results based on 13 studies) for
exposure to cats, and 0.75 (95% CI, 0.67-0.85; I2 5 54%; results
based on 11 studies) for exposure to pets overall. No
heterogeneity emerged across the subgroups examined, except
for geographic area.
Conclusion: This meta-analysis reported a favorable effect of
exposure to dogs and pets on the risk of AD in infants or
children, whereas no association emerged with exposure to cats.
(J Allergy Clin Immunol 2013;132:616-22.)
Key words: Atopic dermatitis, child, epidemiology, hygiene
hypothesis, pets
The hygiene hypothesis has been proposed as a possible
explanation for the apparent increasing prevalence of allergic
diseases, including atopic dermatitis (AD), registered during the
last decades in several high-income countries.1 This hypothesis
assumes that a reduced exposure to infectious agents in early
life can affect the development of the immune system, leading
to increased susceptibility to allergic and autoimmune
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616Along these lines, regular contact with animals and thus
increased exposure to microbial products, including endotoxins,
in pregnancy or during early life (ie, before the inception of
asthma and allergies) has been linked to reduced atopic sensiti-
zation3 and then to various allergic diseases.4-11 In particular, a
decreased risk of asthma and hay fever, but not AD, emerged in
children of farmers,9 pointing toward a favorable role of exposure
to livestock and related bacterial components.12 In a large birth
cohort study from Germany, the development of asthma was not
related to cat and mite allergen exposure in the first years of life
or to cat ownership, although sensitization to mite and cat aller-
gens was associated with indoor exposure.13 Another study con-
ducted in a rural setting considered the role of pets.10 This
found an inverse relation between dog exposure at interview
and diagnoses of asthma and hay fever, although the associations
were somewhat attenuated after allowing for livestock exposure.
On the other hand, only an intensive exposure to cats, but not to
pets in general, was found to prevent asthma in a population of
schoolchildren not living on a farm.11
Earlier reviews and meta-analyses tried to summarize the role
of exposure to pets on asthma and rhinitis. A meta-analysis
reported that exposure to dogs, but not cats, increased the risk of
asthma, whereas exposure to any furry pet decreased the risk of
rhinitis by approximately 20%.14 However, this meta-analysis in-
cluded prevalence studies and was criticized on this and other ba-
ses.15 A subsequent systematic review indicated that most birth
cohort studies report no effect of early-life pet exposure on the
development of asthma and that conflicting findings emerged
across different study designs and methods of assessment of pet
exposure.15,16 Similarly, no effect on asthma or allergic rhinitis
in children aged 6 to 10 years was found in a recent pooled
analysis of birth cohort studies.17
Various, mainly narrative reviews have also been conducted on
AD, which is often the first clinical step in the atopic pathway,
reporting a possible inverse relation with early pet exposure.18,19
Several birth cohort studies have recently provided new results on
the relation between exposure to pets, mainly dogs or cats, and
the risk of AD in children.5,7,20-25 Thus there is the need to quantify
the role of exposure to different pets on the cause of AD by using a
meta-analytic approach and to examine the association in selected
subgroups to address potentialmethodological shortcomings or un-
derlying factors, if anywere present, explaining the relation. In par-
ticular, likely confounding roles of family history of allergic
diseases through an effect of pet avoidance, aswell as of social class
and maternal smoking habits, have been reported.26,27
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between exposure to various pets and AD in infants and children
and to address the role of several covariates, we conducted a
formal systematic review and a meta-analysis of epidemiologic
studies on the issue.METHODS
This systematic review was conducted according to the Meta-analysis of
Observational Studies in Epidemiology (MOOSE) guidelines for reporting
meta-analysis of observational studies.28 We registered this review in the In-
ternational Prospective Register of Systematic Reviews (PROSPERO, regis-
tration no. CRD42012002908), describing in advance the aims and methods
of our investigation.29
In August 2012 we performed a systematic literature search of the Medline
and Embase databases for cohort and case-control studies reporting data on
exposure to pets and AD in infants and children. The following search string,
restricted to the English language, was used in PubMed: ‘‘(case-control OR
cohort OR prospective OR retrospective) AND (eczema OR dermatitis) AND
(pregnancy OR pregnant OR child OR children OR infant OR adolescent)
AND (animals OR pets OR dogs OR cats).’’ A similar combination was
adopted for the Embase search.
Two review team members (C.P. and C.G.) retrieved and independently
assessed the potentially relevant articles and checked the reference lists of all
articles of interest to obtain other pertinent publications. Abstracts and
unpublished studies were not included. No studies were excluded a priori for
weakness of design or data quality, and we did not assign quality scores to the
studies. Each publication identified was included in the analysis if the follow-
ing criteria were met: (1) cohort or case-control studies considering exposure
to dogs, cats, other pets, or pets overall (ie, pet keeping or regular contacts with
pets) during pregnancy, infancy, and/or childhood; (2) AD assessment per-
formed during infancy or childhood (ie, <_12 years of age); and (3) reported es-
timates of odds ratios (ORs) and corresponding 95% CIs or information
sufficient to calculate them for occurrence of AD. We excluded studies that
were (1) cross-sectional; (2) focused on measures of pet exposure other than
pet keeping (eg, sensitization to dogs or cats and pet allergens/endotoxins
measured in the mattress, at home, or at school); (3) studies reporting
outcomes in adolescents or adults; and (4) studies focused on the prognosis
of AD.
We collected data on the number of subjects with and without the disease in
the exposed (ie, to dogs, cats, other pets, or pets overall) and nonexposed
groups; risk estimates (crude and/or adjusted ORs, hazard ratios, or rate ratios,
hereafter collectively defined as relative risks [RRs]) and the corresponding
95% CIs at any available age end point. Furthermore, we abstracted
information on potential sources of heterogeneity or bias across studies,
including details on the population enrolled (ie, children with a family history
of atopic diseases or unselected children), geographic area, period or periods
of pet exposure, outcome assessors, covariate or covariates adjusted for in the
statistical models, and subgroup analyses. Discrepancies between review team
members were discussed and resolved.
We pooled the RR estimates of each study according to exposure to
different pets. For those studies providing only frequency (or percentage)
distributions, we calculated unadjusted ORs and their 95% CIs from the
outcome distribution of exposed and nonexposed children, as reported in the
publications. When multiple estimates from the same study (from >_1 publi-
cations) were available, we included in the main meta-analysis the one study
that fulfilled the following ordered criteria: (1) outcome assessment occurring
at an earlier age4,5,22,30,31; (2) outcome assessment over a time period, rather
than at a given end point (eg, AD up to age 1 year was preferred to AD at age
1 year)4; (3) pet exposure occurring at an earlier age32,33; (4) risk estimate ad-
justed for the largest number of the terms family history of allergic diseases,
parental education/income, parental smoking34,35; and (5) exposure to any pet
rather than to ‘‘dog or cat’’ only.36
We calculated summary RR estimates of AD by using both fixed-effects
models with the inverse variance method (ie, computing an average effect by
weighting the log OR of each study according to the inverse of the samplingvariance) and random-effects models, which consider both within- and
between-study variations by using the DerSimonian and Laird method.37-39
We presented RRs from random-effects models that assume that the exposure
effects observed in the studies are a random sample from a distribution of
exposure effects, thus yielding amore global and conservative estimate.39 Fur-
thermore, random-effects models have the advantage of increasing the accur-
acy of the exposure estimates because the information from the study error
stratum is used in addition to that from the residual stratum. Heterogeneity
between estimates was assessed by using the x2 test and defined as a P value
of less than .10, and inconsistency was measured by using the I2 statistic.40We
also computed summary estimates in several subgroups, including geographic
area, family history of allergic disease, age and period of outcome assessment,
period of exposure, and adjustment for family history of allergic disease, pa-
rental education/income, or parental smoking. In stratified analyses we pre-
sented RRs from random-effects models because the number of studies and
hence the power of the heterogeneity test was low. We used meta-regression
to test heterogeneity between subgroups for study-level, 2-strata covariates
or a heterogeneity test otherwise.41 The presence of publication bias was
assessed by examining the funnel plot and applying the tests proposed by
Begg and Mazumdar42 and Egger et al.43 All the statistical analyses were per-
formed with STATA software (version 11; StataCorp, College Station, Tex).RESULTS
Fig 1 shows the selection process of publications in a flowchart.
Overall, 307 publications were identified in PubMed and 93 in
Embase. By examining the title and abstract, approximately three
fourths of the articles were excluded as irrelevant (eg, studies of
food allergies, atopic or dermatologic diseases other than AD,
sensitization to several allergens, dust mite exposures, and treat-
ment/prognosis and review articles). Furthermore, 20 of the re-
tained publications were present in both databases, leaving 94
unique publications for full-text examination. The review of the
reference lists of these publications led to the identification of 7
additional reports, for a total of 101 articles. After in-depth con-
sideration, 72 publications were excluded (mostly because they
lacked data for pets or analyzed outcomes other than AD, were
cross-sectional studies, or lacked data from original studies).
Thus there were 29 publications that reported original data on
pet exposure and the risk of AD from cohort studies. These
were the basis for ourmeta-analysis. Three of 29 publications44-46
reported duplicate data with other articles and thus were not used
in the overall meta-analysis or in subgroup investigations. These
publications were thus not presented in this review.
Table E1 in this article’s Online Repository at www.jacionline.
org summarizes the main characteristics of the 26 selected publi-
cations reporting data on exposure to pets and risk of
AD.4-7,20-25,30-36,47-55 A few articles were multiple publications
from the same studies, and therefore data were available from a
total of 21 investigations. All of them were birth cohort studies
conducted since 198936 in various areas of Europe (14 studies,
6 of which were from Scandinavian countries alone), the United
States (3 studies), Oceania (3 studies), and Japan (1 study).
With reference to pet exposures considered in these 21 studies,
15 reported data for exposure to dogs, 13 to cats, and 11 to pets
(we included in the latter category also those studies reporting
data for exposure to ‘‘dog or cat’’ only because those were by
far the most common domestic animals kept in the populations
examined). Results for exposure to other domestic animals were
scanty, and thus the subsequent quantitative meta-analyses were
restricted to dogs, cats, and pets overall.
Fig 2 reports the results from each study, as well as overall re-
sults, by using a random-effects model for the relation between
FIG 1. Flowchart for search and selection of publications for the meta-analysis.
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C) and the risk of AD in infants or children. Twelve of 15 RRs for
dog exposure were below unity. The pooled RR of AD for expo-
sure versus no exposure to dogs was 0.72 (95% CI, 0.61-0.85),
with moderate inconsistency observed between studies (I2 5
46%). When we used a fixed-effects model, the pooled RR was
not materially affected (RR, 0.73; 95% CI, 0.65-0.82). With ref-
erence to cat exposure, 6 of 13 RRs of AD were below unity.
When we pooled the estimates, the RR for exposure versus no
exposure to cats was 0.94 (95% CI, 0.76-1.16). Moderate incon-
sistency emerged between studies (I2 5 54%). By using a
fixed-effects model, the pooled RR was unchanged, and the CI
was narrower (RR, 0.94; 95% CI, 0.82-1.08). Six of 7 studies of
any pet exposure (vs no pet exposure) and 3 of 4 studies of dog
or cat exposure (vs no dog or cat exposure) found RRs of AD
of below unity. The corresponding pooled RRs were 0.78 (95%
CI, 0.72-0.85; I2 5 22%) and 0.66 (95% CI, 0.40-1.06; I2 5
78%), with no significant heterogeneity between subgroups
(P 5 .66). Pooling all 11 estimates for pet exposure, the overall
RR of AD was 0.75 (95% CI, 0.67-0.85). For the latter analysis,
moderate inconsistency between studies was found (I2 5 54%).When we performed the analysis of all 11 studies using a fixed-
effects model, the pooled RR was 0.80 (95% CI, 0.75-0.84).
Table I reports the pooled RRs of AD for exposure to dogs,
cats, and pets among several subgroups. No major differences
emerged across the subgroups examined. Even if the within-
group heterogeneity was moderate or high for several strata
(ie, for dog exposure, the I2 value was >60% in >_1 subgroup
for 8/10 strata considered), point estimates remained consis-
tent between strata. In particular, significant heterogeneity
was found only between subgroups of geographic areas for
the relation between dog exposure (P 5 .005) and pet exposure
(P 5 .02) and AD and subgroups of age at outcome assessment
for the relation between pet exposure and AD (P 5 .04), al-
though for the latter, no trend in risk was observed. Further-
more, a borderline significant heterogeneity emerged across
different study designs in the analysis of dog exposure (P 5
.051) and AD. Inconsistency within subgroups was high (ie,
approximately 70%) between studies not adjusted for major
potential covariates and absent between adjusted studies
when we considered the relation between dog exposure
and AD. The opposite finding (ie, no inconsistency between
FIG 2. Summary RRs of AD in subjects exposed to dogs (A), cats (B), and pets overall (C). In Fig 2, A, 2 stud-
ies from Bisgaard et al30 are reported. Both results are extracted from Bisgaard et al, which are from the
COPSAC and MAAS birth cohorts, respectively. The reference category was as follows: no exposure to
dogs in Fig 2, A; no exposure to cats in Fig 2, B; and no exposure to pets (or to dog or cat) in Fig 2, C.
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tween adjusted studies) emerged for the relations between
cat and pet exposure and AD.Fig E1 in this article’s Online Repository at www.jacionline.
org shows the funnel plots of studies on exposure to dogs
(Fig E1, A), cats (Fig E1, B), and pets overall (Fig E1, C) and
TABLE I. Summary RRs of AD in relation to exposure to dogs, cats, and pets, according to selected subgroups
Subgroup
Dogs* Cats Petsy
No. of
studies RR (95% CI) I2
No. of
studies RR (95% CI) I2
No. of
studies RR (95% CI) I2
Geographic area
Europe 9 0.74 (0.61-0.90) 40% 7 0.88 (0.63-1.23) 69% 8 0.73 (0.66-0.82) 48%
United States 3 0.44 (0.31-0.63) 0% 3 0.97 (0.70-1.34) 0% 1 0.56 (0.35-0.90) —
Asia/Oceania 3 0.93 (0.70-1.23) 0% 3 1.13 (0.79-1.63) 25% 2 1.15 (0.86-1.54) 0%
Age at outcome assessment (y)
<_1 10 0.67 (0.53-0.84) 56% 8 0.89 (0.66-1.21) 61% 6 0.74 (0.67-0.81) 0%
>1-<_3 6 0.62 (0.47-0.80) 44% 5 1.01 (0.77-1.32) 50% 6 0.84 (0.73-0.98) 41%
>3 7 0.84 (0.63-1.11) 53% 4 1.05 (0.79-1.40) 0% 4 0.75 (0.53-1.07) 60%
Period of outcome assessment
At an end point (eg, AD at age 1 y) 5 0.68 (0.42-1.10) 73% 5 0.89 (0.60-1.30) 51% 3 0.70 (0.38-1.27) 84%
Up to an end point (eg, AD by age 1 y) 10 0.69 (0.56-0.84) 52% 9 0.95 (0.74-1.20) 57% 9 0.73 (0.63-0.82) 51%
Period of exposure
In pregnancy 1 0.71 (0.48-1.07) — 1 0.68 (0.46-1.00) — 2 0.80 (0.47-1.37) 48%
At birth 5 0.71 (0.45-1.12) 75% 4 1.02 (0.64-1.63) 70% 3 0.78 (0.52-1.18) 75%
After birth 8 0.66 (0.52-0.84) 32% 6 0.89 (0.72-1.10) 0% 5 0.70 (0.57-0.87) 60%
Adjusted for family history of allergic
diseases
No 7 0.76 (0.53-1.09) 71% 6 0.93 (0.73-1.18) 5% 3 0.64 (0.49-0.84) 0%
Yes 8 0.69 (0.59-0.82) 0% 7 0.97 (0.69-1.36) 71% 7 0.80 (0.72-0.90) 50%
Adjusted for education/income
No 8 0.77 (0.58-1.02) 67% 7 0.90 (0.74-1.10) 0% 4 0.64 (0.52-0.80) 0%
Yes 7 0.66 (0.54-0.80) 0% 6 0.96 (0.64-1.44) 75% 6 0.81 (0.72-0.91) 53%
Adjusted for parental smoking/exposure
to ETS
No 8 0.69 (0.50-0.95) 69% 5 1.00 (0.78-1.28) 0% 4 0.69 (0.54-0.88) 0%
Yes 7 0.73 (0.62-0.88) 0% 8 0.92 (0.67-1.26) 69% 6 0.79 (0.71-0.89) 55%
Family history of allergic diseases
No 1 0.80 (0.50-1.40) — 1 0.60 (0.30-1.20) — 2 0.79 (0.70-0.90) 0%
Yes 9 0.66 (0.51-0.85) 40% 8 0.95 (0.72-1.27) 45% 5 0.74 (0.57-0.96) 59%
Studies with unselected populations 7 0.87 (0.67-1.13) 63% 5 0.96 (0.67-1.38) 66% 6 0.73 (0.60-0.88) 56%
Study design
Birth cohort 11 0.70 (0.56-0.87) 61% 8 0.95 (0.70-1.29) 64% 8 0.73 (0.64-0.83) 54%
Birth cohort from other designs
(ie, intervention or case-control studies)
5 0.95 (0.75-1.20) 0% 5 0.92 (0.67-1.26) 43% 3 0.82 (0.57-1.18) 69%
Type of diagnosis
Performed by clinicians/outcome assessors 3 0.86 (0.46-1.59) 49% 3 0.88 (0.57-1.36) 37% 2 0.68 (0.50-0.94) 0%
Reported by parents based on a
physician’s diagnosis or treatment
5 0.66 (0.54-0.82) 0% 4 0.94 (0.67-1.33) 61% 5 0.84 (0.71-1.00) 48%
Self-reported by parents 5 0.74 (0.53-1.04) 72% 3 0.80 (0.52-1.23) 53% 3 0.67 (0.52-0.85) 59%
Others/mixed types 3 0.59 (0.33-1.07) 73% 4 1.13 (0.70-1.84) 61% 1 0.56 (0.35-0.90) —
Overall 15 0.72 (0.61-0.85) 46% 13 0.94 (0.76-1.16) 54% 11 0.75 (0.67-0.85) 54%
All ORs were calculated by using random-effects models. The sum of studies in subgroups might be higher or lower than the total number of studies because some studies, in turn,
provided results for more than 1 subgroup or did not report selected information.
ETS, Environmental tobacco smoke.
*P value for heterogeneity between subgroups of geographic area was .005.
P values for heterogeneity between subgroups were .02 for geographic area and 0.04 for age at outcome assessment.
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looking at the plots or fromEgger and Begg tests for dogs (P5.62
and .15, respectively) and cats (P5.79 and .81, respectively). The
funnel plot for pets was moderately asymmetric, but the Egger
(P 5 .18) and Begg (P 5 .53) tests did not support significant
small-study effects.
DISCUSSION
This meta-analysis of birth cohort studies reported an approx-
imately 25% decreased risk of AD for children who experienced
exposure to dogs and pets overall, whereas no association
emerged with cat exposure. Moderate heterogeneity between
studies was reported, and thus results should be considered withcaution because global estimates could be influenced by con-
founding factors not considered in the analyses. There was no
evidence of publication bias, notwithstanding the fact that all the
identified studies were conducted after the formulation of the
hygiene hypothesis in 1989.2 Furthermore, we considered birth
cohort studies only to avoid possible bias deriving from the inclu-
sion of prevalence studies. Thus our findings for AD are appar-
ently different from those for asthma, which showed no clear
association with pet exposure16 or, if any association were pre-
sent, an increased risk for dog exposure.14
The different role played by pet exposure in patients with AD
compared with those with asthma and hay fever could be due to
the different effects of allergens in these diseases, at least in part.
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onset of asthma and hay fever, whereas pet allergens are not
mainly involved in AD occurrence.
A major issue to be clarified is why a favorable effect on AD
emerged for dog and pet exposure but not for cat keeping. The gut
microbial communities differ across various mammalian spe-
cies.56 In particular, the fecal microbiota of dogs and cats is highly
diverse,57 and it is likely that their skin and mucosal microbiomes
differ as well. Thus, contact with dogs and cats can have a differ-
ent effect on the risk of AD because of the diverse microbial ex-
posures experienced by children living with these animal species.
In fact, changes in the (intestinal) colonization pattern during in-
fancy have been related to the increasing allergy prevalence in
high-income countries58 through an effect of the microflora by
driving the maturation of the immune system.59 Increasing
evidence supports the latter hypothesis.60,61
The stronger inverse association observed in the United States
than inEuropean studies for bothdog andpet exposurewithADand
the lack of association reported in studies from Oceania and Japan
are difficult to explain. The prevalence of pet owners, specifically
cat owners, in a populationmight play a role in thevariation of risks
of allergic diseases (ie, through a community effect).16,62However,
we observed no clear relation between the prevalence of pet keep-
ing and risk estimates of AD in the identified studies. Differences
between populations in handling a dog/pet (eg, kept inside or out-
side the house and level of animal contact with infants/children)
and a role of gene-environment interactions4,30,63,64 are other tenta-
tive explanations for the geographic variation in risks. In any case
only aminority of studieswere conducted outsideEurope, thus lim-
iting the scope for interpretation.
One of the major difficulties in the investigation of the relation
betweenpet exposure andADis the roleof familyhistory of allergic
disease. In fact, the presence of allergy in the family, besides
increasing the risk of allergic disease in the child, might lead to the
avoidance or removal of pets, in particular cats,65 from the home
and thus to reverse causation. We tried to overcome this problem
by excluding cross-sectional studies, which are more prone to
this problem,66 using,when available, estimates adjusted for family
history of allergy and bymeans of subgroup analyses. Furthermore,
summary estimateswere notmaterially different among studies ad-
justing or not adjusting for family history of allergy, as well as
among studies based on children with a family history of allergy
or unselectedwith respect to the latter factor. However, only a small
number of studies provided results among children with no family
history of allergy. Another reassuring consideration against the role
of reverse causation derives from the different results obtained for
dog and cat exposure on AD risk because such bias would be
expected to equally affect both relationships4 or, if any effect is
present, to have a larger effect on the relation with cats.
In all 3 meta-analyses of dogs, cats, and pets and AD, results
from different studies were moderately heterogeneous, with the I2
value for inconsistency ranging between 45% and 55%. This
might be due to the fact that studies differed widely in their
methods; that is, they were conducted among different popula-
tions using diverse diagnostic procedures and end points, assessed
exposures at various ages, and were adjusted for different covari-
ates. When we considered these aspects in subgroup analyses,
however, we could not find any specific factor that adequately ex-
plained the inconsistency.
It was not possible to stratify studies directly by adjustment for
pet avoidance behavior of parents.19 To obviate this problem, weused family history of allergy as a proxy variable of pet avoidance.
This might be suitable for prospective studies, although some
limits of this approach have been previously discussed.5,26 The
number of studies was relatively small, and consequently, the sta-
tistical power of some subgroup analyses was limited. For exam-
ple, our meta-analysis was not informative on the role of maternal
pet exposure during pregnancy because only 2 studies had data on
the issue.25,52 We also considered the role of pet exposure on
IgE-associated AD, as in our previous meta-analysis of probiotic
use,67 but data were available from 1 cohort study only (reporting
ORs of 0.56 [95% CI, 0.28-1.14] at age 2 years and 1.05 [95% CI
0.61-1.81] at age 5 years for exposure to dog or cat).7
The favorable effect of dog exposure onADmight be explained
by the role of contact with microbial agents during early life,
affecting the development of the immune system. Our findings
thus provide support to the hygiene hypothesis.
We thank Dr Lorenzo Moja for advice on conducting the meta-analysis.
Key messages
d Exposure to dogs decreased the risk of AD in children by
approximately 25%, whereas no association emerged with
cat exposure.
d The association might be explained by the role of contact
with microbial agents during early life, affecting the de-
velopment of the immune system.
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FIG E1. Funnel plots of studies on exposure to dogs (A), cats (B), and pets
overall (C) and risk of AD.
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TABLE E1. Publications from epidemiologic studies on exposure to pets and risk of AD included in the main meta-analysis or in subgroup analysis
Reference Country
Period of
enrollment
Age at follow-
up’s end
Study design
(name)
Pet
exposure
Period of
exposure
assessment
Outcome
assessment
for AD
Type of
diagnosis
No. of
subjects
Adjustment
factors
Data for
subgroups
Alm et al,
200920
Sweden 2003 1 y Birth cohort
(IWS)
1: Dog
2: Cat (NS, NR)
3: Bird
4: Rodent
NR Up to age 1 y Self-reported 4,953 None: An
adjusted model
was used in
analysis on
dogs, but ORs
were not
reported.
None
Almqvist et al,
201021
Australia 1997-1999 5 y Birth cohort
(CAPS) from
an RCT on
house dust
mite avoidance
and fatty acid
intake for the
prevention of
asthma and
allergic
diseases
1: Dog
2: Cat
Up to age 5 y At age 5 y Presence at
inspection or
parental report
of itchy rash
and use of
creams/seeking
medical care
referred to the
last 12 mo
516 children
with family
history of
asthma or
wheeze and
without a
cat at
prenatal
enrollment
1: Sex, older
siblings,
family history
of asthma,
maternal
smoking
during
pregnancy,
breast-feeding,
intervention
group
2: Same as 1, plus
environmental
tobacco smoke
None
Isle of Wight cohort
Arshad,
199136
United
Kingdom
1989-1990 1 y Birth cohort
(Isle of
Wight)
Any pet At age 1 y At age 1 y Physical
examination
1,111 None None
Arshad et al,
199355
United
Kingdom
1989-1990 2 y Birth cohort
(Isle of
Wight)
Dog or cat At age 2 y At age 2 y Physical
examination
1,174 None None
Tariq et al,
199854
United
Kingdom
1989-1990 4 y Birth cohort
(Isle of
Wight)
Any pet At age 4 y At age 4 y Physical
examination
1,218 None None
CCAAPS cohort
Biagini
Myers et
al, 201022
United
States
2001-2003 3 y Birth cohort
(CCAAPS)
1: Dog
2: Cat
At age 6-7 mo At age 1 y; up to
age 3 y; at both
ages 2 and 3 y
Parental report or
positive
physical
examination
762 children
with >_1
atopic
parent
None None
Epstein et al,
201149
United
States
2001-2003 4 y Birth cohort
(CCAAPS)
1: Dog
2: Cat
Up to age 1 y
(home visit)
At age 4 y Parental report 636 children
with >_1
atopic
parent
None African
Americans
COPSAC cohort
Bisgaard,
200830
Denmark
and United
Kingdom
1998-2001
(COPSAC)
1995-1997
(MAAS)
1 y Two birth
cohorts
(COPSAC
and MAAS)
1: Dog
2: Both dog and
cat (not
allowing to
compute ORs
for ‘‘dog or
cat’’)
At birth Up to age 1 y
(hazard ratio)
Clinical
examination
(COPSAC) or
parental report
(MAAS)
379 children
of mothers
with asthma
(COPSAC)
and 503
unselected
children
(MAAS)
None COPSAC and
MAAS
separately: cat
exposure,
according to
filaggrin
mutations
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Bisgaard et
al, 200923
Denmark 1998-2001 3 y Birth cohort
(COPSAC)
1: Dog
2: Cat
At birth Up to age 3 y Physical
examination or
history of AD
collected by
the doctor.
Hanifin and
Rajka criteria
356 children
of mothers
with asthma
1: NR, based on
stepwise
selection
2: None
Parental
sensitization
to dogs
COAST cohort
Bufford et al,
200847
United
States
1998-2000 3 y Birth cohort
(COAST)
1: Dog
2: Cat (NS, NR)
At birth; at age 3
y
Up to age 3 y; at
age 3 y
Diagnosed by a
physician (by
documents or
reported by a
parent)
275 children
with >_1
parent with
respiratory
allergy
and/or
asthma
Ethnicity, older
siblings, day
care
attendance,
RSV infection
in infancy,
smoke
exposure in
infancy,
maternal and
paternal
history of
asthma and
allergy, family
income,
maternal and
paternal
education
None
Gern et al,
20044
United
States
1998-2001 1 y Birth cohort
(COAST)
1: Dog
2: Cat
3: Both dog and
cat (allowing
to compute
ORs for ‘‘dog
or cat’’ as well)
At birth Up to age 1 y;
at age 1 y
Diagnosed by a
physician (by
documents or
reported by a
parent)
285 children
with >_1 parent
with
respiratory
allergy or
asthma
None Dog exposure
by CD14
genotype
GINI cohort
Chen et al,
200832
Germany 1995-1998
(GINI)
1997-1999
(LISA)
6 y Birth cohorts
(LISA and
GINI: the
latter
is a 2-arm
study: 1
interventional
and 1 non-
interventional)
Dog Up to age 1 y; up
to age 4 y
Between ages 4
and 6 y
Self-report of
doctor-
diagnosed AD
(data on
presence of
symptoms of
AD were also
given)
2,083 (GINI1, non-
intervention)
and 1,632
(GINI2,
intervention)
children with
family history
of allergic
disease and
2,171
unselected
children
(LISA)
Sex, parental
history of
allergy,
parental
education and
study center:
Further ORs
adjusted for cat
ownership and
frequent
contact with
cats were
given. Results
were
unaffected.
None
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TABLE E1. (Continued)
Reference Country
Period of
enrollment
Age at follow-
up’s end
Study design
(name)
Pet
exposure
Period of
exposure
assessment
Outcome
assessment
for AD
Type of
diagnosis
No. of
subjects
Adjustment
factors
Data for
subgroups
Zirngibl et al,
200231
Germany 1996-1998 2 y Birth cohort
(GINI, a 2-arm
study, 1
interventional
and 1 non-
interventional)
1: Dog
2: Cat
3: Hamster,
rabbit, or
guinea pig
4: Other
5: Any pet
Up to age 1 y Up to age 1 y;
between ages
1 and 2 y
Parental report of
a physician’s
diagnosis of
AD
4,578 Sex, siblings,
family history
of atopic
diseases,
parental
education and
nationality,
living
surroundings,
environmental
tobacco
smoke,
gestational
age, breast-
feeding, study
area, and study
group
None
Dunlop et al,
200648
Slovak
Republic
1997-1999 1 y Birth cohort 1: Cat
2: Bird
3: Other furred
pet (ie, dog,
hamster,
guinea pig,
rabbit)
NR Up to age 1 y Physical
examination
yielding a
SCORAD
score >2 or
physician’s
diagnosis
reported by
parents
1,326 Family history of
atopy, parental
education,
region,
residential
factors, fuel
used for
heating and
cooking,
parental
smoking,
household
exposures,
pregnancy
factors and
infant feeding
None
Kerkhof et al,
200350
The
Netherlands
1996-1997 1 y Birth cohort
(PIAMA,
intervention
arm from a
double-blind
placebo-
controlled trial
on preventive
effect of
mattress
covers)
1: Dog
2: Cat
NR At 1 y (vs never
AD)
Physical
examination,
according to
the modified
UK Working
Party criteria
304 children
of mothers
with
respiratory
allergy or
asthma
Sex, siblings, day
care
attendance,
birth weight,
gestational
age, age of
mother, region,
parental
education,
parental
smoking, and
breast-feeding
Cat and dog
exposure
according to
presence or
absence of
symptoms of
AD at 3 mo
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Linneberg et
al, 200634
Denmark 1997-2002 1.5 y Birth cohort
(DNBC)
Any pet Up to age 1.5 y Up to age 1.5 y Maternal report
of a physician’s
diagnosis of
AD and
recurrent rash
with relevant
localization
34,793 Sex older
siblings,
season of
birth, head
circumference,
birth weight,
day care before
6 mo, parental
history of
allergy,
maternal age
and
occupation,
farm
residence,
family income,
gestational
age, smoking
during
pregnancy,
and breast-
feeding
None
Lodge et al,
20125
Australia 1990-1994 12 y Birth cohort
(MACS) of
an RCT on
infant
formulas
1: Cat
2: Dog
3: Dog or cat
At birth At age 2 y; at age
7 y; at age 12 y
Doctor
consultation
for AD or
treatment
620 children
with >_1
parent or
sibling with
history of
allergic
diseases (359
followed until
12 y of age)
Sex, parental
history of
asthma, AD,
hay fever and
atopy, parental
smoking status,
household
carpets, and
government
assistance
None
Ludvigsson
et al,
200551
Sweden 1997-1999 1 y Birth cohort
(ABIS)
Furred pets (ie,
dog, cat, or
guinea pig)
NR Up to age 1 y;
severe AD (ie,
>_3 AD
episodes)
Maternal report 8,346 Siblings, preterm
birth, family
history of
atopy, parental
smoking status,
maternal
education, and
breast-feeding
Family history of
atopy
Miyake et al,
200752
Japan 2001-1003 2-9 mo Birth cohort
(OMCHS)
Indoor domestic
pets (ie, dog,
cat, bird, or
hamster)
During pregnancy Up to age 2-9 mo Maternal report of
diagnosis or
treatment for
AD
865 Sex, older
siblings, birth
weight,
parental
history of
atopic
diseases,
maternal age,
gestational
age, family
income,
parental
education, and
time of
delivery before
second survey
None
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TABLE E1. (Continued)
Reference Country
Period of
enrollment
Age at follow-
up’s end
Study design
(name)
Pet
exposure
Period of
exposure
assessment
Outcome
assessment
for AD
Type of
diagnosis
No. of
subjects
Adjustment
factors
Data for
subgroups
Nafstad et al,
20016
Norway 1992-1993 4 y Birth cohort
(OBCS)
1: Dog
2: Cat
3: Any pet
At birth Up to age 6 mo Parental report 2,347 Sex, older
siblings, birth
weight,
parental
history of
atopy,
gestational
age, maternal
education,
family income,
and
environmental
tobacco smoke
History of atopy
in parents
Phipatanakul
et al,
200453
United
States
1994-1996 1 y Birth cohort
(HAAS)
1: Dog
2: Cat
At age 2-3 mo Up to age 1 y Parental report of
a diagnosis of
AD
498 children
with parental
history of
asthma or
allergy
1: Sex, season of
birth, paternal
history of AD,
family income,
maternal IgE
positivity
2: None
None
Purvis et al,
200533
New
Zealand
1995-1997 3.5 y Birth cohort
(ABC,
designed as
a case–control
study of SGA
infants, with
SGA and AGA
infants being
sampled with
different
probabilities
of selection)
1: Dog
2: Cat
Up to age 1 y; at
age 3.5 y
At age 3.5 y Physical
examination,
according to
the modified
UK Working
Party criteria
550 None None
Roduit et al,
201125
Europe (5
countries)
2002-2005 2 y Birth cohort
(PASTURE-
EFRAIM)
1: Dog
2: Cat
3: Any pet
During pregnancy
(third
trimester)
Up to age 2 y Parental report of
a physician’s
diagnosis of
AD
1,063 Sex, maternal
history of
atopic
diseases,
maternal
smoking
during
pregnancy,
farming status,
and center
Exposure to cats
by various
subgroups of
Toll-like
receptor
genotypes
Sandini et al,
20117
Finland 2000-2003 5 y Birth cohort
of an RCT
of probiotic
use
Dog or cat Up to age 2 y; up
to age 5 y
Up to age 2 y; up
to age 5 y:
Results for
IgE-associated
AD were also
given.
Physical
examination
934 children
with >_1
parent with
allergic disease
Allocation group
(probiotics or
placebo) and
interaction
term (treatment
group*presence
of dog/cat)
None J
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PIPO cohort
Sariachvili et
al, 200735
Belgium 1997-2001 1 y Birth cohort
(PIPO)
1: Dog
2: Cat
Up to age 1 y Up to age 1 y Parental report 976 Sex, siblings,
day care
attendance,
parental
history of
atopy, maternal
education and
age, passive
smoking of
the child,
pregnancy
duration, active
and passive
smoking
during
pregnancy, and
use of
antibiotics
during
pregnancy
and first year
None
Dom et al,
201024
Belgium 1997-2001 4 y Birth cohort
(PIPO)
Dog or cat Up to age 4 y,
before or at
AD onset
Up to age 4 y Parental report 773 NR None
Data from the same birth cohorts for the Isle of Wight cohort,36,54,55 the COPSAC cohort,23,30 the COAST cohort,4,47 the CCAAPS cohort,22,49 and the PIPO cohort.24,35 The GINI cohort31,32 had partially overlapping subjects.
AD, Atopic dermatitis; AGA, appropriate for gestational age; NR, not reported; NS, not significant; RCT, randomized clinical trial; RSV, respiratory syncytial virus; SGA, small for gestational age.
J
A
L
L
E
R
G
Y
C
L
IN
IM
M
U
N
O
L
V
O
L
U
M
E
1
3
2
,
N
U
M
B
E
R
3
P
E
L
U
C
C
H
I
E
T
A
L
6
2
2
.e
7
